ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 53866 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 53866; 2) Community: the network communities that were significantly associated with the response to NSC 53866; 3) Molecule: the relationships between components within communities and NSC 53866; 4) MDR: the compounds that were significantly associated with the NSC 53866.

NSC Compound Enrichment Correlation
NSC 685862 Null 0.00592008956008459 -0.097895592
NSC 686940 Null 0.00592008956008459 0.56754696
NSC 701378 3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- 0.00592008956008459 0.059538547
NSC 730478 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-5-androsten-3.beta.,17.beta.-diol 0.00592008956008459 -0.093764975
NSC 735037 Camptothecin Derivative 0.00592008956008459 0.11508114
NSC 748705 Null 0.00592008956008459 0.46574058
NSC 750038 Null 0.00592008956008459 0.66461831
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.00592008956008459 0.3612973
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.00592008956008459 0.23233286
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.00592008956008459 0.13893199
Total:68  Current:10    [First] [Prev] [Next] [Last]